Taipei, Taiwan

Szu-Hua Pan


Average Co-Inventor Count = 5.3

ph-index = 1


Company Filing History:


Years Active: 2020-2024

Loading Chart...
3 patents (USPTO):

Title: Innovations of Szu-Hua Pan in Medical Chemistry

Introduction

Szu-Hua Pan is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical chemistry, particularly in the development of compounds for treating proliferative and infectious diseases. With a total of three patents to his name, his work has the potential to impact the treatment of serious health conditions.

Latest Patents

Szu-Hua Pan's latest patents include innovative compounds such as 4,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives. These compounds are designed for use in treating proliferative diseases, including various forms of cancer, such as lung cancer, as well as infectious diseases like bacterial infections. The patents detail the formulations and pharmaceutically acceptable salts that enhance the efficacy of these compounds in medical applications.

Career Highlights

Throughout his career, Szu-Hua Pan has been associated with prestigious institutions such as Academia Sinica and National Taiwan University. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly. His dedication to innovation in medical chemistry is evident through his successful patent applications.

Collaborations

Szu-Hua Pan has collaborated with notable scientists in his field, including Chi-Huey Wong and Pan-Chyr Yang. These collaborations have fostered a rich environment for research and development, leading to groundbreaking discoveries in the treatment of diseases.

Conclusion

Szu-Hua Pan's contributions to medical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…